AlphaGrep UK’s Clorox CLX Stock Holding History

AlphaGrep UK’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$366K	Buy	4,516 +908	+25%	+$87.3K	0.11%	396
2026 Q2	$344K	Buy	+3,608	New	+$346K	0.1%	395

Other funds holding CLX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

VanEck Associates New York $165B AUM 72.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Beutel, Goodman & Co Toronto, Ontario, Canada $12.7B AUM 12.76% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

AlphaGrep UK's CLX Position: Q3 2026 in Review

AlphaGrep UK increased its Clorox (CLX) stake by 25% in Q3 2026, buying an estimated $87.3K and bringing the position to 4,516 shares worth $366K. The position accounts for 0.11% of the portfolio, ranked #396.

AlphaGrep UK first reported a position in CLX in Q2 2026 and has held it in 2 quarters since. 832 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

AlphaGrep UK held 4,516 shares of Clorox worth $366K as of Q3 2026.
AlphaGrep UK bought 908 Clorox shares in Q3 2026, an estimated $87.3K.
Clorox made up 0.11% of AlphaGrep UK's portfolio in Q3 2026, its #396 holding.
AlphaGrep UK first reported a position in Clorox in Q2 2026 and has held it in 2 quarters since.
832 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.